Lyphe Group 🇬🇧
“From prescription to patient, the complete cannabis journey.”
Lyphe Group is a UK-founded medical cannabis company established in 2019, combining specialist prescribing clinics with pharmaceutical distribution. Lyphe operates one of the largest medical cannabis clinic networks in the UK and partners with EU-GMP certified manufacturers globally.
About Lyphe Group
Lyphe Group was founded in 2019 and has grown into one of the UK's most comprehensive medical cannabis organisations. The group operates across the full patient pathway — from initial consultation through to prescribing and dispensing — making it a vertically integrated player in the UK market.
Lyphe's pharmacy division distributes a wide range of EU-GMP certified cannabis products from licensed international manufacturers. Their clinical division includes specialist prescribing clinics staffed by experienced doctors who work with patients on conditions including chronic pain, PTSD, anxiety and sleep disorders.
The company is deeply committed to advancing medical cannabis in the UK, participating in real-world evidence programmes and working with regulators to improve patient access. Lyphe's integrated model provides patients with seamless access to medical cannabis from consultation to delivery.
Certifications & Standards
Home Office Licensed, Pharmacy Registered (GPhC), EU-GMP Supply Chain
How to Get a Medical Cannabis Prescription
Entirely online — no GP referral needed. Most patients prescribed within 5–10 days.
Medical cannabis is a Schedule 2 controlled drug available on private prescription from GMC-registered specialists.
Full Beginner Guide →